A Phase I study of 'Tomudex' and gemcitabine in advanced cancer

被引：1
|
作者：
Cripps, C
Batist, G
Dahrouge, S
Fry, D
McQuillan, A
Kolendowicz, R
Abugaber, AA
机构：
[1] Ottawa Reg Canc Ctr, Ottawa, ON K1Y 4K7, Canada
[2] Jewish Gen Hosp, Clin Res Unit, Quebec City, PQ, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81582-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1162
引用
收藏
页码：S289 / S289
页数：1
相关论文
共 50 条
  • [21] Phase I study of defactinib combined with pembrolizumab and gemcitabine in patients with advanced cancer.
    Wang-Gillam, Andrea
    Lockhart, A. Craig
    Tan, Benjamin R.
    Suresh, Rama
    Lim, Kian-Huat
    Ratner, Lee
    DeNardo, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Combination therapy with infusional 5-FU and 'Tomudex' for patients (pts) with advanced colorectal cancer - A phase I study
    Harstrick, A
    Mayer, S
    Hilger, R
    Muller, C
    Dohmen, D
    Kloppel, R
    Vanhoefer, U
    Scheulen, ME
    Wilke, H
    Seeber, S
    ANNALS OF ONCOLOGY, 1998, 9 : 35 - 36
  • [23] 'Tomudex' (raltitrexed) plus 5FU combination treatment for patients with advanced colorectal cancer: a Phase I study
    Mayer, S
    Hilger, R
    Muller, C
    Dohmen, D
    Kloeppel, R
    Vanhoefer, U
    Scheulen, ME
    Seeber, S
    Harstick, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S74 - S74
  • [24] A phase I study of raltitrexed (Tomudex) combined with carmofur in metastatic colorectal cancer
    Österlund, P
    Elomaa, I
    Virkkunen, P
    Joensuu, H
    ONCOLOGY, 2001, 61 (02) : 113 - 119
  • [25] A phase I study of topotecan and gemcitabine in advanced solid tumors
    Derek S. Serna
    Tanios Bekaii-Saab
    Eric H. Kraut
    Investigational New Drugs, 2011, 29 : 1390 - 1394
  • [26] Gemcitabine and vinorelbine, a phase I study in patients with advanced malignancies
    Chaouche, M
    Delord, JP
    Raymond, E
    Vayre, L
    Ducreux, M
    Ruffle, P
    Rodier, JM
    Armand, JP
    ANNALS OF ONCOLOGY, 1998, 9 : 165 - 165
  • [27] Phase I study of rubitecan and gemcitabine in patients with advanced malignancies
    Fracasso, PM
    Rader, JS
    Govindan, R
    Herzog, TJ
    Arquette, MA
    Denes, A
    Mutch, DG
    Picus, J
    Tan, BR
    Fears, CL
    Goodner, SA
    Sun, SL
    ANNALS OF ONCOLOGY, 2002, 13 (11) : 1819 - 1825
  • [28] A phase I study of topotecan and gemcitabine in advanced solid tumors
    Serna, Derek S.
    Bekaii-Saab, Tanios
    Kraut, Eric H.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1390 - 1394
  • [29] A phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer: A Hoosier Oncology Group study
    Ganjoo, KN
    Gordon, MS
    Sandler, AB
    Warner, RE
    Fife, K
    Poirier, S
    Seshadri, R
    Loehrer, PJ
    ONCOLOGY, 2002, 62 (04) : 299 - 304
  • [30] Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer
    R D Kim
    S R Alberts
    C Peña
    I Genvresse
    A Ajavon-Hartmann
    C Xia
    A Kelly
    J E Grilley-Olson
    British Journal of Cancer, 2018, 118 : 462 - 470
12345